IL1-TRAP, Rilonacept, in Systemic Sclerosis

This study is currently recruiting participants.
Verified November 2013 by Boston University
Sponsor:
Collaborator:
Regeneron Pharmaceuticals
Information provided by (Responsible Party):
Robert Lafyatis, Boston University
ClinicalTrials.gov Identifier:
NCT01538719
First received: February 21, 2012
Last updated: November 7, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)